Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Michael Hunkapiller, Susan Barnes, Jack Schuler, Mark Golden

Pacific Biosciences: Michael Hunkapiller, Susan Barnes

Pacific Biosciences announced that CEO and President Michael Hunkapiller will retire by the end of the year. He plans to remain on the company's board. Hunkapiller served eight years as CEO and oversaw the launch of the Sequel and Sequel II instruments.

Susan Barnes, the firm's CFO and executive VP, will also retire in August after more than a decade with the company.

PacBio said it has already begun searching for their replacements.


Quidel: Jack Schuler

Jack Schuler has retired from Quidel's board, effective June 10, the firm said. Schuler, 79, has been on Quidel's board since February 2006. He was the former president and chief operating officer of Abbott Laboratories.


AACC: Mark Golden

Mark Golden has been appointed the CEO of the American Association for Clinical Chemistry, effective Aug. 17. Prior to joining AACC, he was executive director and CEO of the National Society of Professional Engineers for seven years. AACC had previously said that its current CEO Janet Kreizman would retire from the organization.


For additional recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.